Immunovant
(NASDAQ:IMVT)
$5.62
At close: Aug 12
$5.62
PreMarket: 4:02PM EDT
Day High/Low- - -
52 Week High/Low3.15 - 8.87
Open / Close- / -
Float / Outstanding42.3M / 116.6M
Vol / Avg.- / 304.9K
Mkt Cap655.2M
P/E-
50d Avg. Price4.22
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float42.3M

Immunovant (NASDAQ:IMVT), Earnings Estimates, EPS, and Revenue

Immunovant reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 5

EPS

$-0.350

Quarterly Revenue

$0K

Annual Revenue (as of Jun 30)

Earnings Recap

Immunovant (NASDAQ:IMVT) reported its Q1 earnings results on Friday, August 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Immunovant beat estimated earnings by 12.5%, reporting an EPS of $-0.35 versus an estimate of $-0.4.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 4.85% drop in the share price the next day.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of Immunovant using advanced sorting and filters.

Date
time
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert

Immunovant Questions & Answers

Q
When is Immunovant (NASDAQ:IMVT) reporting earnings?
A

Immunovant (IMVT) is scheduled to report earnings on November 4, 2022. The last reported earnings were for reported on August 5, 2022 for Q1.

Q
What were the latest earnings per share (EPS) for Immunovant (NASDAQ:IMVT)?
A

The Actual EPS was $-0.38, which missed the estimate of $0.00.

Q
What were Immunovant’s (NASDAQ:IMVT) revenues?
A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.